[Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of type 2 diabetic patients]. [PDF]
Canadell-Vilarrasa L +5 more
europepmc +1 more source
[Research trends on botulinum toxin A in bruxism: a bibliometric analysis]. [PDF]
Vargas-Echeverría SL +2 more
europepmc +1 more source
[Health technology assessment in Ecuador's ministry of public health as a tool for drug purchasing from 2012 to 2015]. [PDF]
Armijos L, Escalante S, Villacrés T.
europepmc +1 more source
[The Usefulness of Neuromodulators in Clinical Practice: The Gastroenterologist's Viewpoint]. [PDF]
García-Zermeño KR +3 more
europepmc +1 more source
[Implantation of a program for polymedicated patients within the framework of the Galician Strategy for Integrated Chronic Care]. [PDF]
Reboredo-García S +2 more
europepmc +1 more source
Obesity and cardiovascular risk: a primer for the clinician. [PDF]
Araiza-Garaygordobil D +2 more
europepmc +1 more source
[Evaluation of a programme to monitor drug therapy in type-2 diabetics]. [PDF]
Fornos Pérez JA +3 more
europepmc +1 more source
[Phenotypic Classification of Diabetes: A Personalized Approach for Pharmaceutical Practice].
García Soláns J.
europepmc +1 more source
[Clinical outcomes of percutaneous intervention on the unprotected left main coronary artery]. [PDF]
Quintana-Ortiz EU +5 more
europepmc +1 more source

